September 24, 2021
Article
Only about 60% of Americans have immunity, a number too low to protect the country through “herd immunity,” according to a new report.
In a departure from the independent APIC advisors, CDC Director Rochelle Walensky, MD, has decided to recommend boosters for people in high-risk occupations.
September 23, 2021
The Advisory Committee on Immunization Practices posed a series of 4 questions related to a potential third shot of the Pfizer-BioNTech COVID-19 vaccine in various populations.
A third dose booster vaccination given to persons 60 years of age or over in Israel was confirmed to lower their rate of COVID-19 infection compared to a 2-dose regimen.
New research shows COVID-19 mortality risk to be more nuanced than previous studies.
The federal agency will grant an Emergency Use Authorization (EUA) for the third dose for seniors, those deemed high risk, and those with jobs that put them at risk of infection.
September 22, 2021
A presentation of available third-dose data suggest the adverse event rate is consistent with that observed with second doses.
Patients with cancer now have official confirmation that vaccinating against COVID-19 will protect them from contracting the virus.
September 21, 2021
Video
With the Delta cases surging in recent weeks, and the upcoming flu season almost upon us, here is a glimpse of what providers and the public can expect when both viruses are circulating.
After two doses of the Pfizer-BioNTech COVID-19 vaccine, 83% of allogeneic hematopoietic stem cell transplant recipients showed positive antibody response.
